Patienteninformation
Juli 2014
PLOS ONE | www.plosone.org
September 2014 | Volume 9 | Issue 9 | e103657
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880
Published June 17, 2014
treat TB
Description of Research Outputs, 2009 - 2014
braz j infect dis. 2014;18(5):491–495
http://dx.doi.org/10.1016/j.bjid.2014.02.004
1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
Guidelines for planning and provision of pastoral and social support services
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
Report of Meeting: 4 November 2014, Roma
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...ted measures to reduce the number of fever cases due to malaria
WHO recommends specific adaptations in the diagnosis of malaria and in LLIN distribution in countries heavily affected by the Ebola outbreak and mass drug administration using artemisinin-based combination therapies (ACTs) in areas where transmission of both Ebola and malaria is high and access to malaria treatment is very low.
more
J. European Academy of Dermatology and Venereology, 4 August 2014
Antimicrobial Resistance and Infection Control 2014,3 :31
Training for staff working at DR-TB management centres.
Training modules
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.